Tag: Office of Biotechnology Activities
FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.

Existing regulations serve to hinder access to treatment by making it prohibitively expensive.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org